MINI FUTURE LONG - MERCK & CO. | Market Closed - Euronext Paris 17:30:01 28/06/2024 BST | ||
| 5.41 EUR | -0.44% |
|
| Current month | +8.14% | ||
| 1 month | +6.83% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 5.46 | +0.48% |
| 27/06/24 | 5.434 | -7.55% |
| 26/06/24 | 5.878 | +0.91% |
| 25/06/24 | 5.825 | +1.09% |
| 24/06/24 | 5.762 | +4.44% |
Real-time Euronext Paris
Last update June 28, 2024 at 05:30 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| 6P4MB | |
| ISIN | NLBNPNL2KFH3 |
| Date issued | 15/11/2023 |
| Strike | 70.51 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.16 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.986 € |
|---|---|
| Lowest since issue | 2.835 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
123.8
USD
Average target price
142.7
USD
Spread / Average Target
+15.25%
- Stock Market
- Certificates
- 6P4MB Certificat
